The study evaluated whether pre-existing rheumatoid arthritis was associated with a higher mortality and risk for immune-related adverse events with immune checkpoint inhibitor use.
Joining Dr. Ishizawar in conducting this research were 黑料网 colleagues; Dr. Amanda Lusa, Dr. Todd Schwartz, Carolina Alvarez, and Shruti Saxena Beem.
Learn more about the study findings via this summary in .
Rumey Ishizawar, MD, PhD, is an assistant professor of medicine in the Division of Rheumatology, Allergy and Immunology.聽